GNMSF:OTCMKTS
Genmab A/S
$355.00
arrow_upward
+0.57%(+2.00) 1D
Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Open
$355.00
High
$355.00
Low
$355.00
Mkt. cap
22.02B
Avg. vol.
1.59K
Volume
100.00
52-wk high
$355.00
52-wk low
$232.50
Beta
0.77
Shares outstanding
62.41M
No. of employees
3K
Open
$355.00
High
$355.00
Low
$355.00
Mkt. cap
22.02B
Avg. vol.
1.59K
Volume
100.00
52-wk high
$355.00
52-wk low
$232.50
Beta
0.77
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
TipRanks
·
7 hours ago
Genmab Updates Capital Structure and Articles of Association in September 2026 SEC Filing
AD HOC NEWS
·
14 hours ago
Genmab stock reflects higher 2026 revenue guidance
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com